5 Top 2013 Advances in Gastrointestinal Cancer

Share on Facebook
Here are five leading advances in the study and treatment of gastrointestinal cancer in 2013, according to Medscape’s Top Clinical Cancer Advances: ASCO 2013 Report.

    1.    S-1 chemotherapy improves survival rate in pancreatic cancer patients.
    2.    Nab-paclitaxel earned approval for use in pancreatic cancer treatment.
    3.    Colorectal cancer with NRAS mutations is unlikely to benefit from panitumumab.
    4.    Capecitabine and bevacizumab are standar maintenance therapy in colorectal cancer.
    5.    Octreotide LA prolongs survival in midgut neuroendocrine tumors.

More Articles on Gastroenterology:
6 Things to Know About Infliximab as Ulcerative Colitis Treatment
5 Recent GI-Driven Center Openings & Plans
The Promise of Stem Cell Treatment for Crohn’s Disease & Ulcerative Colitis: Q&A With Dr. William Katkov

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

MEDARVA Stony Point Surgery Center performs 30 free colonoscopies for patients in need

Read Now